Haemonetics Corporation (HAE) /

The cash flow of Haemonetics Corporation over the past 10 years

Chart Haemonetics Corporation: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2026 Open the chart →

In fiscal 2026, the latest fiscal year on file, Haemonetics Corporation's operating cash flow was $293.22M and its capital expenditures $32.78M, leaving free cash flow of $260.44M. Free cash flow was above zero in all 10 years shown. It ranged from $40.32M in fiscal 2019 to $260.44M in fiscal 2026. Capital expenditures were highest in fiscal 2023, at $191.33M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2026ended Mar 28, 2026$293.22M$32.78M$260.44M
2025ended Mar 29, 2025$181.72M$39.28M$142.45M
2024ended Mar 30, 2024$181.75M$38.13M$143.63M
2023ended Apr 1, 2023$273.06M$191.33M$81.73M
2022ended Apr 2, 2022$172.26M$96.51M$75.75M
2021ended Apr 3, 2021$108.81M$37.04M$71.77M
2020ended Mar 28, 2020$158.22M$48.76M$109.46M
2019ended Mar 30, 2019$159.28M$118.96M$40.32M
2018ended Mar 31, 2018$220.35M$74.8M$145.55M
2017ended Apr 1, 2017$159.74M$76.14M$83.6M

Fiscal years as Haemonetics Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Haemonetics Corporation

Companies of a similar size

Not investment advice. This page shows what Haemonetics Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.